Delivery Order SPE2DB24D2010-SPE2DB24FZTY6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,461.21, is a delivery order for the delivery of 4,563,773,922 units of the medication Vyvanse 40 mg capsule. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award, valued at $17,124.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for Vyvanse 60 mg capsules in 100-count bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award, valued at $1,121.24, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order contract is for the supply of Vyvanse 50 mg capsules. It is a firm-fixed-price contract with an ultimate completion date of April 28, 2023. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,589.62, is a delivery order for 4,563,357,333 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 19, 2024 and is a firm fixed-price arrangement. This award is not associated with any set-aside designation, indicating full...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,008.89 firm-fixed-price delivery order is for the supply of Vyvanse 40 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC enables the efficient procurement of a...
- This federal contract award, valued at $3,741.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,558,623,390 capsules of the prescription medication Vyvanse 40 mg. The contract is a Firm Fixed Price Delivery Order with a completion date of September 28, 2022. This award is not associated with a set-aside program and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 40 mg capsules. The $3,963.97 Firm Fixed Price delivery order falls under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
- This federal contract award, valued at $11,186.99, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,556,143,203 units of the prescription medication Vyvanse 40 mg capsule. The contract is a Firm Fixed Price Delivery Order with a completion date of February 2, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,556,838,348 units of the pharmaceutical product Vyvanse 20 mg capsule. The contract, valued at $45,250.44, was awarded by the Defense Logistics Agency (DLA) on April 8, 2022, with an ultimate completion date of April 11, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $11,810.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse 40 mg capsules and is a Firm Fixed Price Delivery Order with a completion date of May 7, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTY6Delivery Order
This federal contract award, valued at $1,318.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,450,813 units of the pharmaceutical product Vyvanse 40 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has established itself as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/30/24 |